Study of HCV Genotype 1 Patients in the UK Treated With ViraferonPeg and Rebetol (Study P05269)(COMPLETED)
Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The study is designed as a retrospective data review of medical records from participants
selected from specialist secondary and tertiary care centers across the United Kingdom (UK),
specializing in Hepatitis C treatment. The study is non-interventional and is designed to
identify subgroups of Hepatitis C Virus (HCV) genotype 1 participants in the 'real world',
including the relation between subgroup characteristics and treatment responsiveness.